Akebia Therapeutics

3 followers

‌

Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology.

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

201-500

Links

Org chart

John Butler

President & CEO

John Butler

Collapse

Steven K. Burke

SVP R&D & Chief Medical Officer

Meredith Bowman

SVP & Chief People Officer

Kimberly Garko

SVP & CTO

Erik Ostrowski

SVP, CFO & Chief Business Officer

Tracey Vetterick

VP, Portfolio Strategy & Corporate Administration

Ann Grosse

Director, Alliance Management And Business Development

Carolann Reiber

Director, Pharmacovigilance Operations And Alliance Management

Karen Harrigan

Senior Director Medical Engagement Strategy

Michael Donovan

Sr. Director Information Security

Nicholas Grund

SVP & Chief Commercial Officer

Graham Ray

Vice President Of Sales

Candy Liang

Senior Director, Corporate Development And New Product Planning

Alfredo Grossi (Freddie)

Vice President, Technical Operations

Christian Barnes

Senior Director, Business Development

Karine Moreau

Senior Director, Commercial Excellence

Lourette A.

Director Of Operations

Nicole Corcoran

Senior Director, Market Access And Commercial Operations

Chrissy Robinson

Executive Assistant, Legal

Teams

+15

Medical and Clinical Operations

18 members

+10

Sales and Commercial Operations

13 members

Finance Team

12 members

+10

Key Account Management

13 members

Leadership Team

5 members

Operations

5 members

Offices

Similar companies

Neuralink

63 followers

Seres Therapeutics

3 followers

Travere Therapeutics

2 followers

ACM Global

1 follower

Thermo Fisher Scientific

176 followers

Genentech

160 followers

Biogen

122 followers

Exact Sciences

18 followers

PerkinElmer

9 followers

Oxford Nanopore Technologies

8 followers

Neurocrine Biosciences

7 followers

Explore companies

��������